BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $1,195,552 (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 39.5%

Value ($000) $472,773 Shares 4,656,488 Est. Cost $22.71 Unrealized +113.3%

STAA STAAR SURGICAL CO 35.7%

Value ($000) $426,331 Shares 8,783,082 Est. Cost $9.40 Unrealized +567.5%

AXON AXON ENTERPRISE INC 10.5%

Value ($000) $126,117 Shares 760,062 Est. Cost $27.50 Unrealized +474.9%

IWM ISHARES TR 10.1%

Value ($000) $120,308 Shares 690,000 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 3.4%

Value ($000) $40,875 Shares 34,935,485 Est. Cost $1.04 Unrealized +20.6%

— ONCOCYTE CORP 0.6%

Value ($000) $7,494 Shares 23,353,697 Est. Cost $2.75 Unrealized —

— AGEX THERAPEUTICS INC 0.1%

Value ($000) $1,654 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$472,773	39.5%	$22.71	+113.3%	COM	61174X109
STAA	STAAR SURGICAL CO	8,783,082	$426,331	35.7%	$9.40	+567.5%	COM PAR $0.01	852312305
AXON	AXON ENTERPRISE INC	760,062	$126,117	10.5%	$27.50	+474.9%	COM	05464C101
IWM	ISHARES TR	690,000	$120,308	10.1%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$40,875	3.4%	$1.04	+20.6%	COM	53566P109
—	ONCOCYTE CORP	23,353,697	$7,494	0.6%	$2.75	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$1,654	0.1%	$2.99	—	COM	00848H108